TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Smerud Medical Research International AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,116
|
8,455
|
5,990 |
| Financial expenses |
124
|
187
|
270 |
| Earnings before taxes |
877
|
1,793
|
552 |
| Total assets |
4,019
|
3,573
|
4,509 |
| Current assets |
3,670
|
3,192
|
4,088 |
| Current liabilities |
1,786
|
1,984
|
3,292 |
| Equity capital |
2,233
|
1,589
|
1,218 |
| - share capital |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
55.6%
|
44.5%
|
27.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
9.6%
|
21.2%
|
9.2% |
| Return on assets (ROA) |
24.9%
|
55.4%
|
18.2% |
| Current ratio |
205.5%
|
160.9%
|
124.2% |
| Return on equity (ROE) |
39.3%
|
112.8%
|
45.3% |
| Change turnover |
1,093
|
2,845
|
2,706 |
| Change turnover % |
14%
|
51%
|
82% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.